Tolloids are a small group of highlyconserved astacin-like zinc metalloproteinases that occur in all metazoa, from flies to humans. They are essential for normal development because they cleave precursors of extracellular matrix macromolecules (at least in vertebrates) and antagonists of bone morphogenetic proteins (in flies, worms and vertebrates). By cleaving precursors of extracellular matrix macromolecules (see below for details), tolloids initiate the assembly of tissues. How tolloids distinguish between different substrates is not well understood.
BMP-1 1 , which is one of the best studied tolloids, was originally isolated from osteogenic extracts of bone (1) (2) (3) and is a small splice variant of the bmp1 gene. The larger splice variant of the bmp1 gene is mammalian tolloid (mTLD). Two additional genes give rise to two further tolloid proteinases in vertebrates, namely mammalian tolloid like-1 (mTLL-1) and -2 (mTLL-2) (4, 5) . BMP-1, mTLD, mTLL-1 and mTLL-2 have (from the N-terminus) a signal peptide, a prodomain, an astacin-like metalloproteinase domain, two consecutive CUB domains, an EGF-like domain and a third CUB domain. mTLD, mTLL-1 and mTLL-2 have an additional EGFlike domain and two additional CUB domains (6) . All proteins have a unique short sequence at the C-terminus.
The amino acid sequences immediately Nterminal of the metalloproteinase domains of tolloids contain a consensus cleavage site for furin-like proprotein convertases. Subsequently it has been shown that the prodomain of proBMP-1 is removed in the trans Golgi network by dibasic proprotein convertases (7) . Presumably cleavage of the prodomain of the other tolloids by a similar mechanism explains the appearance of active proteinases in the medium of cultured cells. The EGF-like domains, which in other proteins are thought to be involved in calcium binding (8) , have recently been ruled out as the domains responsible for calcium ion dependency of tolloids (9) . CUB domains are wide-spread modules which have been described to mediate protein-protein interactions in a range of molecules with diverse functions (10) .
BMP-1 exhibits procollagen C-proteinase (PCP) activity because it cleaves the Cpropeptides of the major fibrillar procollagens 1-III (11) (12) (13) . Cleavage of the C-propeptides is both necessary and sufficient to initiate the self-assembly of collagen fibrils (see (14) and references therein). BMP-1 also cleaves amino acid sequences within the minor fibrillar procollagens V and XI (15, 16) . BMP-1 cleavage of procollagen V is different in important ways from the cleavage of the major fibrillar procollagens because it can cleave sequences within the non-triple helical Npropeptide domains (see (17) and references therein). BMP-1 cleaves other substrates including chordin (4) , which is a BMP antagonist, prolysyl oxidase (18, 19) , which is required for the formation of covalent crosslinks in collagen and elastic fibers (20) , as well as myostatin, a transforming growth factorfamily member essential for regulation of skeletal muscle growth (21) . BMP-1 also cleaves the precursors of biglycan (22) , osteoglycin (23) , procollagen VII (24) , laminin V (25, 26) , and dentin matrix protein-1 (27) .
The tolloid enzymes present overlapping enzymatic activities i.e. tolloid substrates are cleavable by more than one tolloid proteinase (e.g. procollagen I is cleavable by BMP-1 and mTLL-1) and tolloid proteinases can cleave more than one substrate (e.g. BMP-1 cleaves procollagen I and chordin). This redundancy is demonstrated in BMP-1/mTld null mice that have abnormal collagen fibrillogenesis in skin, are perinatal lethal because of delayed ventral wall closure but lack gross abnormalities of most connective tissues and exhibit normal anatomy (28) . A notable exception is BMP-1 and mTLL-2; BMP-1 is an effective PCP whereas mTLL-2 will not cleave fibrillar procollagens (at least in the absence of PCPE) (12). Similarly, chordin and its Drosophila homologue short gastrulation (sog) (29, 30) , is cleavable by BMP-1 but not by mTLL-2 (4,31). Cleavage of chordin allows BMP2/4 and BMP4/7 to bind and signal via cognate plasma membrane receptors (32) (33) (34) . Similarly, cleavage of sog enhances the activity of decapentaplegic (35, 36) .
In this study, we tested the hypothesis that substrate specificity is determined by the catalytic and non-catalytic domains of tolloids. We generated a series of chimeric molecules containing different combinations of proteinase and CUB domains originating from either BMP-1 or mTLL-2, and we expressed and assayed the mutant proteins in vitro. We found that the metalloproteinase and CUB2 domains from BMP-1 were required for PCP activity; the equivalent domains from mTLL-2 were inactive. We also showed that the mTLL-2 proteinase domain possesses chordinase activity if CUB1 from BMP-1 was part of the same molecule. We showed that a minimal structure for chordinase activity comprises a tolloid metalloproteinase domain and the CUB1 of BMP-1, and hence is shorter that the minimal sequence for PCP activity (37).
The procollagen C-proteinase activity of BMP-1 is enhanced by procollagen Cproteinase enhancer-1 (PCPE-1), which is an extracellular matrix glycoprotein. PCPE-1 enhances the PCP activity of tolloid metalloproteinases up to 20-fold (38) but lacks intrinsic PCP activity. PCPE-1 consists of two N-terminal CUB domains and a C-terminal NTR (netrin-like) domain (39) . While BMP-1 has numerous substrates, it is unknown if PCPE-1 is able to enhance cleavage of substrates other than procollagen. A recent study suggests that PCPE-1 is specific to procollagen I, II and III (40) .
The mechanism of PCP enhancement by PCPE-1 is unknown. Studies have suggested that PCPE-1 acts by causing a conformational change in the substrate (41,42). Furthermore, it has been shown that the stoichiometry of the interaction requires a 1:1 ratio of PCPE-1:procollagen indicating that the stimulation occurs via its interaction with the substrate and not the enzyme. To test this model we assayed BMP-1 in the presence of PCPE-1 and chordin, which is a substrate unrelated to procollagen. As a further test of the model we examined the ability of PCPE-1 to enhance the PCP activity of the minimal procollagen Cproteinase which lacks the EGF and CUB3 domains of the molecule. However, the PCP activity of BMP-1 was more enhanced more by PCPE-1 than the minimal PCP. Also, we show that PCPE-1 does not enhance the ability of BMP-1 to cleave chordin. The data show that PCPE-1 appears to function via the procollagen substrate but that the CUB3 domain of BMP-1 might augment the interaction.
EXPERIMENTAL PROCEDURES
Source of Materials -Full-length BMP-1 cDNA (GenBank accession number NM_001199) was cloned from a human placental cDNA library. A FLAG tag amino acid sequence (DYKDDDDK) was introduced into the BMP-1 sequence (BMP-1-FLAG) immediately 5' of the stop codon. The cDNA encoding FLAG-tagged BMP-1 was subcloned into the episomal expression vector pCEP4 (InVitrogen) (37). Human mammalian tolloid like-2 (mTLL-2) (GenBank accession number AF_059516) was obtained by synthesis of the sequence from position 1497 to the stop codon (Genscript, USA). A V5-FLAG tag amino acid sequence (GKPIPNPLLGLDST-DYKDDDDKG) was introduced into the mTLL-2 sequence immediately 5' of the stop codon. The FLAG epitope is recognized by a mouse monoclonal anti-FLAG M2 antibody (Sigma). An XhoI restriction site was introduced after the stop codon for cloning purposes. The synthesized cDNA in pUC18 (Life Technologies) was digested by PmlI (position 1503) and XhoI (after the stop codon) and ligated into the mTLL-2 IMAGE clone cDNA (IMAGE cDNA clone number 3836889) in pCEP4, hence forming the mTLL-2-FLAG cDNA clone. A KpnI restriction enzyme site was introduced 5' to the start codon of the mTLL-2 cDNA sequence by PCR for cloning purposes and to remove a false start codon occurring in the 5' untranslated region of IMAGE clone cDNA sequence. The full-length human chordin cDNA (GenBank accession number NM_003741) (43) , was cloned, tagged and tested for activity as described previously (9) . The c-myc tag (EQKLISEEDL) (44) , recognized by antibody 9E10 (Roche Molecular Biochemicals), was introduced in full-length human chordin between the putative signal peptidase cleavage site and CR1, 14 residues after the cleavage site (after amino acid 40). The c-myc tagged chordin was subcloned into the episomal expression vector pCEP4 (Invitrogen) and used in 293-EBNA cells transfection (9) . Site Directed Mutagenesis -A full-length BMP-1-FLAG cDNA clone, a (M-C1-C2) B -FLAG clone (i.e. missing the EGF like and CUB3 domains) and a (M-C1) B -FLAG clone (i.e. missing the CUB2, EGF-like and CUB3 domains) (37) with a NotI site after the metalloproteinase domain were used to generate the chimeric proteins, by excising and re-cloning the respective fragment from the mTLL-2 clone. The wild-type and deletion mutant BMP-1 cDNA clones had a KpnI site at the 5'end and an XhoI site at the 3' end for cloning purposes. For the generation of the chimeras, two fragments were amplified by PCR, using Pfx polymerase (InVitrogen) as described (37). The first fragment consisted of the mTLL-2 cDNA sequence up to the end of the metalloproteinase domain. A KpnI restriction enzyme site was introduced at the 5' end and a NotI site at the 3' end of the fragment for cloning purposes. The second fragment consisted of the mTLL-2 cDNA sequence constituting CUB1 and CUB2. A NotI site was introduced 5' of CUB1 and a FLAG epitope sequence, a stop codon and an XhoI restriction enzyme site 3' of CUB2. The mTLL-2 IMAGE clone in pOTB7 (Life Technologies) was used as a template. For the first fragment, the primers used were a forward primer with the sequence (5'-CGCGGTACCATGCCCCGGGCG-3') and a reverse primer with the sequence (5'-CCCACATGCGGCCGCCGCTGGGCATTT-3'). For the second fragment, the primers used were a forward primer with the sequence (5'-GTGCCCAGCCGCGGCCGCATGTGGGGA GA -3') and a reverse primer with the sequence (5'-CCCCCCTCGAGTCACTTGTCATCGTCGT CCTTGTAGTCCTTGAAAAAATTGGCTGC AAAGCCCGCTTTATTGATAGAG -3'). The PCR products were purified, digested either by KpnI and NotI or by NotI and XhoI and inserted into the BMP-1 clones in pCEP4 to replace the BMP-1 domains with the respective domains from mTLL-2. Specifically, the mTLL-2~BMP-1 chimeras were generated by replacing the sequences corresponding to the signal sequence, the prodomain and the metalloproteinase domain (fragment KpnI to NotI) from BMP-1 with the respective fragment from the mTLL-2 cDNA. Likewise, the BMP-1~mTLL-2 chimeras were generated by replacing the BMP-1 sequence from NotI to XhoI with the fragment containing domains of mTLL-2. DNA sequencing (ABI) was used to verify the replacement, and to ensure that the cDNA clones were error-free. Protein Expression -293-EBNA (ECACC 85120602) cells were maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum (FCS) (GIBCO) and 0.25 mg/ml Geneticin (G418, Life Technologies, Inc) in a 37°C incubator with 5% CO 2 . Wild type or mutant plasmid/T25 were incubated with Lipofectin (InVitrogen) and added to 293-EBNA cells in serum-free OptiMEM (GIBCO), according to the manufacturer's instructions. Twenty-four hours after transfection, media were removed and replaced by DMEM containing 10% serum for a further 24 h. The cells were trypsinized (GIBCO) and diluted 1:5 for selection. After 48 h, selection was initiated by addition of 0.25 mg/ml hygromycin B (InVitrogen). A full-length BMP-1-FLAG cDNA clone, a BMP-1-C3-FLAG clone and a BMP-1-EC3-FLAG clone were expressed in 293-EBNA cells (37). A FLAG-tag was engineered to the C-terminus of recombinant PCPE-1 by PCR. Full length PCPE/pcDNA 3 was used as a template and the PCR reaction involved a forward primer with the sequence (5'-CGCGGTACCATGCTGCCTGCA-3') and a reverse primer with the sequence (5'-CCCCCCTCGAGTCACTTGTCATCGTCGT CCTTGTAGTCGTCCTGGGACGCAGC-3').
The forward primer incorporates a KpnI restriction enzyme site before the ATG start codon of PCPE-1. The reverse primer includes the final 15 bases before the TGA stop codon, the FLAG-tag sequence followed by the stop codon and then an XhoI restriction enzyme site. The KpnI and XhoI sites were introduced for cloning purposes. DNA sequencing (ABI) was used to ensure that the cDNA clones were error-free.
Preparation of Media and Cell Lysates -
Confluent cells were rinsed 3 times with PBS and incubated in DMEM lacking FCS for 24h. Medium was centrifuged for 5 min at 1,600 x g to remove cell debris, and the pH was stabilized by the addition of 1/10 volume of 1 M Tris-HCl buffer (pH 7.4). For preparation of cell lysates, cells were rinsed in PBS and incubated on ice with 500 μl RIPA buffer (150 mM NaCl, 1% sodium deoxycholate, 0.1 % SDS, 10 mM Tris-HCl (pH 7.4) containing 10 mM EDTA, and protease inhibitor mixture (Roche Molecular Biochemicals) for 15 mins with occasional shaking. The cells were scrapped on ice and sonicated. The lysates were clarified by centrifugation at 13,000 x g for 5 min at 4°C. Protein purification -Type I procollagen was purified from the culture medium of primary human fibroblasts, after incubation of the cells with uniformly-labeled 14C-L-amino acids, as described (45) . Flag-tagged proteins were purified from the medium of cultured cells as described (4) . Electrophoresis and Western BlottingSupernatants and cell lysates (see above) were resolved by electrophoresis on a 10% (w/v) SDS-Prosieve gel (BioWhittaker Molecular Applications) under reducing conditions and subjected to Western immunoblotting. The following antibodies were used where appropriate: the mouse monoclonal anti-FLAG antibody (Sigma) followed by the secondary antibody (anti-mouse horseradish peroxidase conjugated IgG (Sigma)); the mouse monoclonal 9E10 directed against the c-myc tag followed by the secondary antibody (antimouse horseradish peroxidase conjugated IgG (Sigma)). The signal was detected by the enhanced chemiluminescence method (SuperSignal West Dura extended duration, Pierce).
Assay of Procollagen C-proteinase and
Chordinase Activities -The wild-type and chimeric proteins were assayed for procollagen C-proteinase activity using human U-L- 14 Cprocollagen I substrate in 50 mM Tris-HCl buffer (pH 7.4) containing 0.12 M NaCl, and 0.01% (w/v) Brij-35 in the presence of 5 mM CaCl 2 , at 37 °C for 16 h. Analysis of the cleavage products on SDS gels (7% separating; 4% stacking) was performed as described (46) , and the cleaved products were visualized by exposing dried gels to a phosphoimager plate (Fuji, type BAS III) in a phosphoimager (Fujix BAS 2000) . One unit of C-proteinase activity was defined as the amount of BMP-1 needed to cleave 1 g type I procollagen in hour at 34ºC, as described (45) . Proteins corresponding to the pro 1(I) and pN 2(I) chains of type I procollagen and type I pNcollagen respectively, were quantified using AIDA 2.0 software. The percent cleavage was calculated by multiplying the intensity of the pN 2(I), corrected for molecular mass, by the initial concentration of procollagen. Chordinase activity was determined in vitro by cleavage of c-myc-tagged chordin in the same buffer as above, for 16 h at 37°C, followed by analysis of the cleavage products on a 10% SDS-Prosieve gel, and Western blot using 9E10 antibody as described above. Where indicated, EDTA was added at a final concentration of 10 mM.
RESULTS

Nomenclature Used to Describe the Chimeric
Proteins -We use the labels M, C1, C2, E and C3 to represent the metalloproteinase, CUB1, CUB2, the most N-terminal EGF-like domain and CUB3 domains of the tolloid family of proteinases. We use 'B' and 'T' in superscript to denote from which tolloid a particular domain has been taken. For example, M T -C1 B is used as a short-hand notation to represent a mature (i.e. lacking the prodomain) chimeric tolloid molecule containing the metalloproteinase domain from mTLL-2 immediately followed (in the N-to Cdirection) by the CUB1 domain from BMP-1. Hyphens are used to avoid confusion. We use parentheses to group together domains from a single tolloid e.g. (M-C1-C2)
T is a truncated molecule containing the metalloproteinase, CUB1 and CUB2 domains of mTLL-2. All molecules were synthesized containing a signal peptide and the prodomain. The signal peptide and prodomains in chimeric proteins were from the same molecule as the metalloproteinase domain e.g. the molecule (M-C1-C2)
T was synthesized with the signal peptide and the prodomain from mTLL-2. All molecules have the FLAG tag at the Cterminus but for brevity this is not indicated in the short-hand labels.
The Chimeric Proteins are Readily Secreted from 293-EBNA Cells -To evaluate the contribution of the metalloproteinase and non catalytic domains to substrate cleavage, we generated a series of chimeric proteins in which the order of the domains remained constant i.e. M-C1-C2-E-C3 but the domains were from either BMP-1 or mTLL-2. These chimeric proteins were produced in 293-EBNA cells by over expression from suitable cDNA vectors (see Fig. 1 ). NotI sites were introduced by PCR between the metalloproteinase domain and CUB1 of BMP-1 and mTLL-2 and restriction enzyme digestion was used to replace the BMP-1 metalloproteinase domain with the mTLL-2 metalloproteinase domain. Previous work showed that the NotI-derived alanine residues do not affect the proteinase activity of BMP-1 when inserted at the junctions between domains (37). The culture media and cell lysates were analyzed separately by SDS-PAGE (10%) under reducing conditions and Western blot analysis was performed using the monoclonal anti-Flag M2 antibody (Fig.  2) . While no immunoreactive bands were found in the medium or cell lysate from cells transfected with pCEP4 empty vector control ( 
Both the Metalloproteinase and CUB2
Domains from BMP-1 are Required for PCP Activity -Previous studies have shown that the CUB2 domain of BMP-1 was important for PCP activity of the molecule (37). However we were not able to evaluate the activity of the metalloproteinase domain in isolation of the remainder of the molecule because this domain (by itself) is not secreted. The satisfactory secretion of chimeric proteins gave us the opportunity to investigate the contribution of each domain without the concern that the proteins were misfolded or not secreted. To evaluate the PCP activity of the chimeras we assayed the secreted proteins using 14 C-labeled procollagen I as substrate, in the presence of 5mM CaCl 2 , at 37°C (Fig. 3) . Whereas BMP-1 was effective at cleaving the C-propeptide of procollagen I, the chimeras exhibited negligible PCP activity, as did mTLL-2. Assays in which 10 mM EDTA were included showed no cleavage of procollagen I (data not shown). Lack of PCP activity for mTLL-2 was consistent with previous reports (4), at least in the absence of PCPE-1 (12). Our results show that PCP activity is affected: (1) by the source of CUB2 because M B -(C1-C2)
T lacks PCP activity, and (2) by the source of the metalloproteinase domain because replacement of M B with M T lacked PCP activity.
The Metalloproteinase Domain of mTLL-2 has the Ability to Cleave Chordin -It was reported previously that chordin is cleaved by BMP-1 but not mTLL-2 (4) thus making chordin a suitable substrate with which to test the hypothesis that substrate cleavage in the tolloid family requires the cooperation of different domains of the molecule. The chimeric proteins (see Fig. 1 ) were incubated with cmyc-tagged human chordin in the presence of 5mM CaCl 2 and the cleavage products were detected by Western blotting using the anti-cmyc antibody (Fig. 4 A and B) . Cleavage of chordin was assayed by the disappearance of the c-myc-tagged full-length chordin and the appearance of a partially digested 98 kDa fragment lacking the C-terminus as well as a smaller 15 kDa partial fragment, both of which contain the c-myc tag (Fig. 4A) . Under the conditions of the assay, c-myc-tagged chordin was stable in the absence of added enzyme (panel B) or in the presence of medium from cells transfected with pCEP4 empty vector control or in the presence of chimeric proteins with 10 mM EDTA present in the assay (data not shown). As expected, mTLL-2 was unable to cleave chordin. In contrast, chordin was cleaved by BMP-1 and M T -(C1-C2-E-C3) B . Therefore, the proteinase domain of mTLL-2 acquires the ability to cleave chordin if attached to the non-catalytic domains of BMP-1.
The Metalloproteinase Domain of MTLL-2 can
cleave Chordin -Previous work suggested that the weak PCP activity of mTLD is explained by the CUB4 and CUB5 domains of the molecule excluding access of procollagen to binding sites on the proteinase (9). We wanted to know if a similar mechanism explained why mTLL-2 (possessing similar CUB4 and CUB5 domains) cannot cleave chordin. To test this hypothesis we generated two chimeras. The first was a mTLL-2 protein truncated at the CUB2 domain (i. . Assay of these proteins using chordin as a substrate showed that neither exhibited chordinase activity (Fig. 4B ). This result indicated that the CUB1 and/or CUB2 domains of mTLL-2 are unable to promote chordin cleavage. Furthermore, the chordinase activity of BMP-1 does not reside solely in the metalloproteinase domain of BMP-1. Still further, the absence of chordinase activity of mTLL-2 is not explained by steric hindrance caused by the CUB4 and 5 domains of the molecule.
To identify the particular CUB domain responsible for chordin specificity in BMP-1 we generated M T (C1-C2) B . This molecule was designed based on the knowledge that the minimal procollagen C-proteinase comprised of the metalloproteinase domain, CUB1 and CUB2 of BMP-1, and was also able to cleave chordin (9,37). Our results show that this chimera, containing the metalloproteinase domain from mTLL-2, can cleave chordin (Fig. 4) . This finding minimized the minimal chordinase to a molecule containing the CUB1 and/or CUB2 domain of BMP-1.
The Minimal Structure for Chordinase Activity
Comprises a Metalloproteinase Domain and the CUB1 of BMP-1 -It remained to be determined if chordinase activity of BMP-1 was associated with CUB1 or CUB2. For this purpose, a chimera comprising the mTLL-2 metalloproteinase and the CUB1 domain of BMP-1 was generated. Our results showed that M T -C1
B was able to cleave chordin (Fig. 4B) . In further experiments we assayed a molecule having the metalloproteinase and CUB1 domains of BMP-1 i.e. (M-C1) B . Noteworthy, this molecule had previously been shown to be devoid of PCP activity (37). Our results indicated that chordin was cleaved by (M-C1) B (Fig. 5) . Cleavage was abolished by EDTA (Fig. 5) .
PCPE-1 Enhances the PCP Activity but has no
Effect on the Chordinase Activity of BMP-1 -FLAG-tagged PCPE-1 (Fig. 6A) was expressed in 293-EBNA cells, as described in "Experimental Procedures". Western blot analysis of the culture medium using the antiFlag M2 antibody showed the presence of a single immunoreactive protein at the expected size for PCPE-1 (~50 kDa) (Fig. 6B) . PCPE-1 has been shown to enhance the PCP activity of BMP-1 up to 20-fold (47) . While this observation was made for fibrillar collagens (41,42), it is not known whether this activity is observed with other substrates. To address this question we evaluated the effect of PCPE-1 on the chordinase activity of BMP-1. As shown in Fig. 6C , BMP-1 was able to cleave c-myctagged chordin at the predicted cleavage sites. Addition of PCPE-1 in varying concentrations did not enhance the chordinase activity of BMP-1 (Fig. 6C ). This is indicated by the appearance of bands of similar intensity at 15kDa, which correspond to the N-terminal cleavage fragment of chordin. The chordinase activity assay was performed in parallel and under identical conditions with assays using procollagen I as substrate. PCPE-1 enhanced the PCP activity of BMP-1 under the same conditions.
The Minimal C-proteinase Exhibits Enhanced PCP Activity in the Presence of PCPE-1 -
PCPE-1 has been shown to bind the Cpropeptide and the triple-helical region of procollagens type I and III (42) . To determine if CUB domains of BMP-1 were necessary for this activity, domain deletion mutants of BMP-1 were assayed alone and in the presence of PCPE-1 (for schematic of the proteins see Fig.  7 ). If the removal of a BMP-1 domain resulted in the loss of the ability of BMP-1 to be enhanced by PCPE-1, then this would suggest that the particular domain was involved in the by guest on http://www.jbc.org/ Downloaded from enhancer activity of PCPE-1. BMP-1-C3-FLAG was initially tested for PCP activity, as described in "Experimental Procedures", alone or in the presence of PCPE-1 (42) . Our results show an increase in procollagen C-propeptide processing in the presence of PCPE-1 (Fig. 8) . BMP-1-EC3-FLAG was then assayed under the same conditions and exhibited an increase in PCP activity in the presence of PCPE-1 albeit not as pronounced as with full-length BMP-1 i.e. containing the CUB3 domain. Our findings suggest that the EGF-like and CUB3 domains of BMP-1 are not necessary for the enhancing ability of PCPE-1. However, the truncated BMP-1 was not enhanced by PCPE-1 as much as full-length BMP-1.
DISCUSSION
In the first part of this study we showed that: (1) the metalloproteinase and CUB2 domains of BMP-1 are required together for PCP activity; (2) the mTLL-2 proteinase domain possesses chordinase activity; (3) CUB1 domain is essential for chordinase activity of BMP-1 and (4) the minimal sequences for BMP-1 chordinase activity are contained within the metalloproteinase and the first CUB domain. These observations show that substrate cleavage within the tolloid family is specified by two separate domains: one is a CUB domain and the second is the metalloproteinase domain. Alternatively, the results are consistent with a model of substrate cleavage in which a CUB domain influences the binding surface of the metalloproteinase domain to facilitate substrate cleavage. Importantly, the appropriate coupling of CUB and proteinase domain determines substrate cleavage.
The difficulty of purifying sufficient amounts of tolloid proteins prevents detailed biophysical and structural studies of tolloidsubstrate interactions. A valid approach has been to study the cleavage of substrates by recombinant proteinases that have either domains deleted or inserted. Previous work highlighted the importance of the non-catalytic domains of BMP-1 in the PCP activity of this enzyme, showing that CUB1 domain and its location immediately adjacent to the metalloproteinase domain were required for the secretion of the molecule, and that CUB2 was essential for PCP activity (37). The role of BMP-1 CUB2 was further illustrated in the present study because the M B -(C1-C2) T chimera lacked PCP activity, showing that the CUB domains of mTLL-2 are unable to promote cleavage of procollagen I, despite high sequence similarity between CUB domains. Also the M T   -(C1-C2-E-C3)  B and M   T   -(C1-C2) B chimeras, that both contain the CUB2 of BMP-1, also lacked PCP activity. This shows that the presence of the BMP-1 CUB2 domain in a chimera is not the only requirement for a procollagen C-proteinase, but that an efficient metalloproteinase domain is necessary as well. Indeed, in these mutants, whereas substrate cleavage via CUB domains can occur as in the wild-type BMP-1, the replacement of the BMP-1 metalloproteinase domain by the one of mTLL-2 abolished PCP activity. Therefore, from these observations, it was expected that M T -C1
B did not exhibit PCP activity because it lacked both the CUB2 and proteinase domain of BMP-1.
It was reported previously that BMP-1, but not mTLL-2, is able to cleave chordin (4). We used this substrate to study if substrate recognition and specificity of the tolloid family involves different domains than those described for procollagen I. The results are consistent with a model of substrate-proteinase interaction in which the CUB domains position the substrate into the active site for cleavage to occur. Thus, the inability of mTLL-2 to cleave chordin could have been the result of: (i) the inability of the metalloproteinase domain to cleave chordin, or (ii) the inability of the mTLL-2 CUB domains to position the metalloproteinase over the scissile bone in chordin. However, the chimeric protein M T -(C1-C2-E-C3) B allowed us to establish that the mTLL-2 metalloproteinase domain possesses intrinsic ability to cleave chordin effectively and that the inability of mTLL-2 to cleave chordin lies in the inability of the mTLL-2 CUB domains to position the proteinase domain on chordin. A surprising observation was that the mTLL-2 metalloproteinase domain, in the same mutant, was unable to process procollagen I. This reinforced the conclusion that substrate recognition and specificity within the tolloid family involves different domains for different substrates. It must be pointed out that mTLL-2 is capable, however weakly, of cleaving procollagen I in the presence of PCPE-1 in vitro (12), indicating that sequences allowing some level of procollagen cleavage do occur in the metalloproteinase domain.
In a previous study we showed that the minimal C-proteinase (comprising the BMP-1 metalloproteinase, CUB1 and CUB2 domains) cleaved chordin (9) . By further deleting the domains CUB3, EGF, and CUB2 of this molecule, it became obvious that CUB1 was essential for chordin cleavage. This adds another function to the CUB1 domain, which is also necessary for the secretion of BMP-1 (37). Thus, (M-C1) B is the minimal chordinase structure.
An explanation for why mTLD is a poor chordinase has been proposed based on a substrate exclusion mechanism, in which CUB4 and 5 sterically block binding of some substrates (9) . This question was further addressed in the present study by the design of the proteins M B -(C1-C2)
T and (M-C1-C2) T , which lack the C-terminal CUB4 and 5 domains. These mutants were shown to be devoid of chordinase activity, showing that CUB1 and 2 of mTLL-2 (and in the light of our other results, CUB1 in particular) cannot facilitate chordin cleavage.
In the second part of this study, we showed that PCPE-1 does not enhance the chordinase activity of BMP-1. PCPE-1 binds procollagen I (42), which suggests that PCPE-1 functions via its interaction with procollagen. However, it is unknown if this interaction extends to other BMP-1 substrates. A test substrate was chordin. The results showed that the inclusion of PCPE-1 in assays of BMP-1 did not affect its ability to cleave chordin. This finding suggests that the mechanism of action of PCPE-1 is substrate specific. Previous work showed that the minimal C-proteinase is an efficient PCP. This finding raised the intriguing possibility that the EGF-like and CUB3 domains might interact with PCPE-1, and thereby explain its ability to potentiate the cleavage of procollagen by BMP-1. Our results showed that PCPE-1 enhances the activity of the minimal PCP. However, its ability to do so was reduced when the EGF and CUB3 domains are absent. Therefore, although evidence suggests that PCPE-1 primarily functions via its interaction with procollagen, the EGF and CUB3 domains of BMP-1 might play an additional role in the ability of PCPE-1 to enhance BMP-1.
From this and previous studies it appears that CUB domains play major roles in defining substrate specificity of the tolloids, as well as regulating folding and secretion (37,48). They also stabilize the structure of the proteinases via N-linked glycosylation (48) and by regulating substrate accessibility to the active site (9) . All these observations are relevant for studies of the folding and assembly of other proteins that contain CUB domains, in particular enzymes with CUB domains adjacent to the proteinase domain such as serine proteases in complement components.
The present study provides a basis for further research aimed at determining the strength of interaction of BMP-1 domains with procollagen and chordin and the molecular recognition surfaces on the relevant domains. This might entail biophysical solution studies, using purified recombinant domains and combinations thereof, combined with x-ray studies of crystallized complexes of BMP-1 and its substrates. Such interaction studies might be compromised by cleavage of the substrates by BMP-1. Cleavage of substrates could be avoided by using activity-null BMP-1 molecules in which the active site aspartic acid is mutated to alanine (46) . However, it is unknown how such mutations would affect substrate binding. Furthermore, cultured 293-EBNA cells secrete only small amounts of BMP-1, which might precluded their use as a source of BMP-1 for structure determination and biophysical study. U-14 C-labeled human procollagen I was incubated in the presence of 5 mM CaCl 2 and the conditioned medium from 293-EBNA cells that had been stably-transfected with vectors encoding wild-type BMP-1 and mTLL-2, and the chimeric proteins. Western blotting using the anti-FLAG antibody was used to normalize levels of proteinases. Products of the reaction were separated on a 7% SDS-gel under reducing conditions. Percentage of procollagen cleavage was calculated as described in "Experimental Procedures", from triplicate experiments (±SE). When confluent, the cells were conditioned in serum-free medium for 24 hours. Culture supernatants were collected as described in "Experimental Procedures". The protein samples were separated by SDS-PAGE (10%) under reducing conditions and detected by Western blot analysis using the monoclonal anti-Flag M2 murine antibody. pCEP 4 : medium and cell lysate from cells transfected with the empty vector. (C) C-myc-tagged chordin secreted from 293-EBNA cells was incubated alone or with BMP-1 in the absence or presence of varying amounts of PCPE-1, as described in "Experimental Procedures". The cleavage products were separated under reducing conditions on a 10% SDS-Prosieve gel and detected by Western blot analysis using the c-myc (9E10) antibody. 
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